@article{3105245,
    title = "Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group",
    author = "Papageorgiou, S.G. and Kontos, C.K. and Kotsianidis, I. and Karousi, P. and Symeonidis, A. and Galanopoulos, A. and Bouchla, A. and Hatzimichael, E. and Repousis, P. and Zikos, P. and Viniou, N.-A. and Poulakidas, E. and Vassilakopoulos, T.P. and Diamantopoulos, P. and Mparmparousi, D. and Bouronikou, E. and Papadaki, H. and Panayiotidis, P. and Pappa, V.",
    journal = "Journal of Geriatric Oncology",
    year = "2020",
    volume = "11",
    number = "1",
    pages = "121-124",
    publisher = "Elsevier Ireland Ltd",
    issn = "1879-4068",
    doi = "10.1016/j.jgo.2019.07.018",
    keywords = "azacitidine;  azacitidine, acute myeloid leukemia;  aged;  bone marrow suppression;  bone marrow toxicity;  cancer growth;  cancer risk;  comorbidity;  controlled study;  drug efficacy;  female;  follow up;  Greece;  human;  International Prognostic Scoring System;  Letter;  major clinical study;  male;  myelodysplastic syndrome;  oligoblastic acute myeloid leukemia;  oligoblastic acute myeloid leukemia;  overall survival;  priority journal;  retrospective study;  single drug dose;  treatment failure;  treatment response;  very elderly, Aged;  Azacitidine;  Greece;  Humans;  Leukemia, Myeloid, Acute;  Myelodysplastic Syndromes;  Retrospective Studies"
}